Cancer immunotherapy and vaccine development have significantly improved the fight
against cancers. Despite these advancements, challenges remain, particularly in the clinical …

The advent of immunotherapy has significantly reshaped the landscape of cancer treatment,
greatly enhancing therapeutic outcomes for multiple types of cancer. However, only a small …

Malignant melanoma (MM) is the most common and deadliest type of skin cancer and is
associated with high mortality rates across all races and ethnicities. Although present …

Ferroptosis is a recently recognized form of cell death with distinct features in terms of
morphology, biochemistry, and molecular mechanisms. Unlike other types of cell death …

A synergistic combination of treatment with immunogenic cell death (ICD) inducers and
immunoadjuvants may be a practical way to boost the anticancer response and successfully …

Immunotherapies for cancer, specifically immune checkpoint inhibition (ICI), have shown
potential in reactivating the body's immune response against tumors. However, there are …

Melanoma, a highly aggressive skin tumor, exhibits notable features including
heterogeneity, a high mutational load, and innate immune escape. Despite advancements in …

The incidence of melanoma, the most lethal form of skin cancer, has increased due to
ultraviolet exposure. The treatment of advanced melanoma, particularly metastatic cases …

Melanoma is a highly malignant skin cancer that is known for its resistance to treatments. In
recent years, there has been significant progress in the study of non-apoptotic cell death …

Cancer vaccines based on single-source (exogenous or endogenous) tumor-associated
antigens (TAAs) are often challenged by the insufficient T cell response and the …